ELIGARD PACKAGE INSERT PDF

ELIGARD (leuprolide acetate) is indicated for the palliative due to incorrect reconstitution or administration of the product (see Monitoring and Laboratory .. Gently insert the long, white replacement plunger rod into the gray. PACKAGE LEAFLET: INFORMATION FOR THE USER. ELIGARD 45 mg powder and solvent for solution for injection. Leuprorelin acetate. Read all of this leaflet. Eligard® is a sterile polymeric matrix formulation of leuprorelin acetate for subcutaneous package insert for constitution and administration procedures.

Author: Kijinn Temuro
Country: Sao Tome and Principe
Language: English (Spanish)
Genre: Technology
Published (Last): 23 November 2016
Pages: 284
PDF File Size: 15.93 Mb
ePub File Size: 7.82 Mb
ISBN: 704-8-52999-280-1
Downloads: 24955
Price: Free* [*Free Regsitration Required]
Uploader: Akinokree

Oops Something Went Wrong!

In patients with endometriosis, this reversible hypoestrogenic state produces symptomatic relief of the pain of endometriosis and decreases the number of endometriotic lesions. Treatment with clozapine has been associated with QT prolongation, torsade de pointes TdPcardiac arrest, and sudden death.

Once mixed, the product must be administered within 30 minutes. Excessive doses particularly in the overdose setting or IV administration of haloperidol may be associated with a higher risk of QT prolongation. Consider periodic monitoring of electrocardiogram ECG and electrolytes.

Eligard (leuprolide acetate) dose, indications, adverse effects, interactions from

An ECG should also be performed at least 2, 12, and 24 weeks after starting bedaquiline therapy. Lofexidine prolongs the QT interval. Subcutaneous dosage solution for injection. The authors concluded paackage LHRH-agonist therapy cannot be routinely recommended to augment height in short adolescents with normally timed puberty; for most adolescents the potential benefit of treatment would not outweigh the risks. Antipsychotic-induced hyperprolactinemia results in down-regulatation of the number of pituitary GnRH receptors and may interfere with the response to any of the gonadotropin-releasing hormone GnRH analogs e.

The recommended dose is 15 mg IM as a single dose repeated every 4 weeks. Withhold HCG administration in cases where the ovaries are abnormally enlarged to reduce the chance of inducing ovarian hyperstimulation eljgard OHSS.

In clinical trials, QT prolongation has been reported in patients who received midostaurin as single-agent therapy or in combination with cytarabine and daunorubicin. Androgen deprivation therapy prolongs the QT interval; the risk may be increased with the concurrent use of drugs that may prolong the QT inswrt. Hold the syringe upright. Major The administration of lumefantrine is associated with prolongation of the QT interval.

Halogenated anesthetics should be used cautiously and with close monitoring in patients receiving leuprolide. Leuprolide is administered subcutaneously or intramuscularly.

After a brief increase in serum testosterone levels, testosterone was suppressed to castrate levels from week 4 to week 48 in Additionally, antipsychotic-induced hyperprolactinemia results in down-regulatation of the number of pituitary GnRH receptors and may interfere with the response to leuprolide therapy. Normally, GnRH is released in a pulsatile fashion, but the sustained activity of leuprolide leads to downregulation of the receptor and decreased production of follicle-stimulating hormone FSH and luteinizing hormone LH.

PDR Search

Chlorpromazine is specifically associated with an established risk of QT prolongation and TdP ; case reports have included patients receiving therapeutic doses of chlorpromazine.

We do not record any personal information entered above. eligagd

Seizures have been reported during postmarketing surveillance in patients with a history of epilepsy, cerebrovascular disease, central nervous system anomalies or brain tumor, and patients on concomitant medications that have been associated with seizures.

Be sure to rotate injection sites when dose is next due. After reconstitution, the suspension settles very paackage therefore, mix and administer the suspension immediately. Drugs with a possible risk for QT prolongation and TdP that should be used cautiously and with close monitoring with leuprolide include procainamide.

Several dosage regimens are possible, depending on the depot dosage used. Manage patients according to current clinical practice. Drugs with a possible elitard for QT prolongation and TdP that should be used cautiously and with close monitoring with leuprolide include gemifloxacin.

Drugs with a possible risk for QT prolongation and TdP that should be used cautiously with leuprolide include vorinostat. Discard any suspension not used within 2 hours of reconstitution because it does not contain preservatives. Depot IM injection Administration: Recipient’s Email Separate multiple email address with a comma Please enter valid email address Recipient’s email is required.

Use with caution and with close clinical monitoring with amiodarone.

VPN